Arruda E, Pitkäranta A, Witek T J, Doyle C A, Hayden F G
Department of Internal Medicine, University of Virginia School of Medicine, Charlottesville 22908, USA.
J Clin Microbiol. 1997 Nov;35(11):2864-8. doi: 10.1128/jcm.35.11.2864-2868.1997.
Human rhinovirus (HRV) accounts for a significant portion of common-cold illness, with the peak incidence being in the early fall. Three hundred forty-six adults who had self-diagnosed colds of 48 h or less were enrolled in a study during September and October 1994 to determine the frequency and clinical course of HRV infections. Nasal wash specimens for viral culture and reverse transcription-PCR (RT-PCR) for HRV RNA and human coronavirus OC43 and 229E RNA detection were collected on enrollment, and participants recorded their symptoms twice daily for 14 days. Middle ear pressure (MEP) was measured with a digital tympanometer on days 1 and 7. Picornaviruses (224 HRV and 7 enterovirus isolates) were detected by culture in 67% (231 of 346) of the subjects. Among 114 samples negative by culture, HRV was detected by RT-PCR in 52 (46%) for an overall picornavirus infection rate of 82% (283 of 346 subjects). Among the remaining 62 negative samples, human coronavirus RNA was detected by RT-PCR in 5 patients, so that 288 (83%) of patients had documented viral infection. The first symptom noticed most often was sore throat (40%) in HRV culture- or PCR-positive patients and stuffy nose in HRV-negative patients (27%). No differences in symptom scores over time or in the presence of individual symptoms were noted between groups. The median duration of the cold episodes was 11 days in HRV culture-positive patients, 9.5 days in HRV RT-PCR-positive patients, and 11.5 days in HRV-negative patients. On enrollment, abnormal MEPs (< or = -100 or > or = +100 mm of H2O) were found for 21% of HRV culture-positive patients, 14% of HRV RT-PCR-positive patients, and 10% of HRV-negative patients. No important differences in the clinical course of HRV culture-positive, HRV culture-negative and RT-PCR-positive, or HRV-negative colds were found. These results represent the highest frequency of virologically confirmed natural colds to date and document the importance of rhinoviruses as the cause of colds during fall months.
人鼻病毒(HRV)在普通感冒疾病中占很大比例,发病高峰期在初秋。1994年9月和10月,346名自我诊断感冒时间在48小时及以内的成年人参与了一项研究,以确定HRV感染的频率和临床病程。入组时采集鼻洗液标本进行病毒培养,并进行逆转录-聚合酶链反应(RT-PCR)检测HRV RNA以及人冠状病毒OC43和229E RNA,参与者连续14天每天记录两次症状。在第1天和第7天用数字鼓室计测量中耳压力(MEP)。通过培养在67%(346名中的231名)的受试者中检测到微小核糖核酸病毒(224株HRV和7株肠道病毒分离株)。在114份培养阴性的样本中,通过RT-PCR在52份(46%)中检测到HRV,总体微小核糖核酸病毒感染率为82%(346名受试者中的283名)。在其余62份阴性样本中,通过RT-PCR在5名患者中检测到人类冠状病毒RNA,因此288名(83%)患者有病毒感染记录。HRV培养或PCR阳性患者中最常出现的首个症状是喉咙痛(40%),HRV阴性患者中则是鼻塞(27%)。两组之间在症状评分随时间的变化或个别症状的出现方面未发现差异。HRV培养阳性患者感冒发作的中位持续时间为11天,HRV RT-PCR阳性患者为9.5天,HRV阴性患者为11.5天。入组时,21%的HRV培养阳性患者、14%的HRV RT-PCR阳性患者和10%的HRV阴性患者发现中耳压力异常(≤-100或≥+100 mmH2O)。在HRV培养阳性、HRV培养阴性及RT-PCR阳性或HRV阴性感冒的临床病程方面未发现重要差异。这些结果代表了迄今为止病毒学确诊的自然感冒的最高频率,并证明了鼻病毒作为秋季感冒病因的重要性。